Literature DB >> 23052669

Predicting left ventricular recovery after replacement of a regurgitant aortic valve in pediatric and young adult patients: is it ever too late?

Daniel A Cox1, Kara Walton, Peter J Bartz, James S Tweddell, Peter C Frommelt, Michael G Earing.   

Abstract

The management of pediatric and adolescent patients with pure aortic valve regurgitation remains challenging and controversial (Christos et al., Eur J Cardiothorac Surg 17:125-133, 2000; Gersony and Sommerville, ACC Curr J Rev 31:97-98, 2000; Hasaniya et al., J Thorac Cardiovasc Surg 127:970-974, 2004; Sabet et al., Mayo Clin 74:14-26, 1999; Tweddell et al., J Thorac Cardiovasc Surg 129:551-558, 2005). We evaluated pediatric and young adult patients who underwent aortic valve replacement (AVR) primarily for aortic regurgitation in an effort to identify preoperative echocardiographic variables that are predictive of left ventricular (LV) recovery following AVR. Twenty-one patients with severe aortic valve regurgitation who underwent AVR were identified. Retrospective chart review for each patient was performed and transthoracic echocardiograms prior to and 6-months after AVR were analyzed. Improvement in LV size based on preoperative LV end-systolic dimension index when compared to 6-months post-AVR was observed in 68% of the patients. Patients with persistent dilation of their left ventricles had a greater preoperative LV end-systolic dimension index (p ≤ 0.05), a greater preoperative LV end-systolic dimension z-score (p ≤ 0.002), and a lower preoperative ejection fraction (EF) (p ≤ 0.001). A similar trend was present between the two cohorts in regards to LV end-diastolic parameters (LV end-diastolic dimension index and z-score), with patients with abnormal LV size at 6-month follow-up having larger preoperative dimensions. Increasing LV systolic dimensions and declining EF appear to be predictors of poor LV recovery following AVR in pediatric and young adult patients. LV end-systolic indices appear to be more predictive than LV end-diastolic indices. AVR should be performed prior to severe LV enlargement defined as an LV end-systolic dimension z-score >4.5.

Entities:  

Mesh:

Year:  2012        PMID: 23052669     DOI: 10.1007/s00246-012-0529-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  Predictors of long-term survival after valve replacement for chronic aortic regurgitation; is M-mode echocardiography sufficient?

Authors:  R Corti; C Binggeli; M Turina; R Jenni; T F Lüscher; J Turina
Journal:  Eur Heart J       Date:  2001-05       Impact factor: 29.983

2.  Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council.

Authors:  Leo Lopez; Steven D Colan; Peter C Frommelt; Gregory J Ensing; Kathleen Kendall; Adel K Younoszai; Wyman W Lai; Tal Geva
Journal:  J Am Soc Echocardiogr       Date:  2010-05       Impact factor: 5.251

3.  Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study.

Authors:  K S Dujardin; M Enriquez-Sarano; H V Schaff; K R Bailey; J B Seward; A J Tajik
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

4.  Complex aortic valve repair as a durable and effective alternative to valve replacement in children with aortic valve disease.

Authors:  James S Tweddell; Andrew N Pelech; Peter C Frommelt; Robert D B Jaquiss; George M Hoffman; Kathleen A Mussatto; S Bert Litwin
Journal:  J Thorac Cardiovasc Surg       Date:  2005-03       Impact factor: 5.209

5.  Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases.

Authors:  H Y Sabet; W D Edwards; H D Tazelaar; R C Daly
Journal:  Mayo Clin Proc       Date:  1999-01       Impact factor: 7.616

6.  Morphologic determinants favoring surgical aortic valvuloplasty versus pulmonary autograft aortic valve replacement in children.

Authors:  J A van Son; V M Reddy; M D Black; H Rajasinghe; G S Haas; F L Hanley
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

7.  Is repair of aortic valve regurgitation a safe alternative to valve replacement?

Authors:  Kenji Minakata; Hartzell V Schaff; Kenton J Zehr; Joseph A Dearani; Richard C Daly; Thomas A Orszulak; Francisco J Puga; Gordon K Danielson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

8.  Outcome of aortic valve repair in children with congenital aortic valve insufficiency.

Authors:  Nahidh Hasaniya; Steven R Gundry; Anees J Razzouk; Neda Mulla; Leonard L Bailey
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

9.  Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study.

Authors:  Michael D Pettersen; Wei Du; Mary Ellen Skeens; Richard A Humes
Journal:  J Am Soc Echocardiogr       Date:  2008-04-11       Impact factor: 5.251

10.  Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function.

Authors:  R O Bonow; E Lakatos; B J Maron; S E Epstein
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

View more
  2 in total

1.  Direct measurement of aortic regurgitation with phase-contrast magnetic resonance is inaccurate: proposal of an alternative method of quantification.

Authors:  Yoichi Iwamoto; Akio Inage; George Tomlinson; Kyong Jin Lee; Lars Grosse-Wortmann; Mike Seed; Andrea Wan; Shi-Joon Yoo
Journal:  Pediatr Radiol       Date:  2014-06-18

2.  Holodiastolic Flow Reversal at the Descending Aorta on Cardiac Magnetic Resonance is Neither Sensitive Nor Specific for Significant Aortic Regurgitation in Patients with Congenital Heart Disease.

Authors:  Catherine M Avitabile; Kevin K Whitehead; Mark A Fogel; Daniel W Kim; Timothy S Kim; Julian D Rose; Marc S Keller; Gregory L Fu; Matthew A Harris
Journal:  Pediatr Cardiol       Date:  2016-06-16       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.